Creo Medical Group PLC (BST:1RC)

Market Cap	76.20M +20.8%
Revenue (ttm)	6.88M +50.0%
Net Income	6.08M
EPS	0.01
Shares Out	n/a
PE Ratio	12.54
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.1470
Previous Close	0.1470
Day's Range	0.1450 - 0.1590
52-Week Range	0.1050 - 0.2100
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 29, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develops CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. It also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needle ablati...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2003
• Employees: 104
• Stock Exchange: Stuttgart Stock Exchange
• Ticker Symbol: 1RC

Financial Performance

Financial numbers in GBP

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 29, 2026

Data Sources Report a data error